عندما لا يحل CPAP انقطاع التنفس المركزي الناجم عن العلاج

References

DOI: 10.1183/20734735.0235-2023

1. The emergence or persistence of CSA during therapy for upper airway obstruction (often associated with CPAP, but can also occur with non-PAP OSA treatment modalities) is termed complex sleep apnoea or treatment-emergent CSA (TECSA).
2. In ∼30% of patients with persistent CSA at 90 days, CPAP can be switched to ASV or bilevel PAP spontaneous/timed modes to reduce AHI and improve adherence (ASV appears superior to bilevel PAP due to sustained response).
3. Enhanced expiratory rebreathing space may also be a solution as it prevents all the exhaled air from being vented through the CPAP mask.